Intellectual property
Vectura’s intellectual property is a valuable asset that underpins its past, present and future success. The Group aims to secure multi-layered registered protection for its products, processes and technology platforms, which has the potential to provide highly effective protection.
Vectura’s patent portfolio includes over 130 families of patents and patent applications, covering inventions made by the Group’s researchers as well as inventions the Group has acquired or licensed from third parties. The Group actively maintains and protects this patent estate.
Additional value continues to be obtained from Vectura’s intellectual property estate from licensing its rights for the development of non-pulmonary products, for example, Baxter International Inc. is licensed to use certain of Vectura’s patents for ADVATE®, Adept® and Extraneal® products, which are sold on the market.
